Title: Director of Innovative Methods
Company: VaxDesign Campus, Sanofi
Location: Orlando, Florida, United States
Anatoly Kachurin, PhD, Director of Innovative Methods at the VaxDesign Campus of Sanofi, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in the development of molecular and biological assessments of immune response.
Inspired by his older brother Alexey Kachurin, a biophysicist, Dr. Kachurin followed a similar path under the guidance of Professor Symon E. Bresler, one of the founders of biophysics in the Soviet Union and a head of Biophysics Department in the Leningrad Polytechnic Institute of Russia. Dr. Kachurin’s professional career culminated in his current role with Sanofi, where he excels as Director of Innovative Methods of the VaxDesign Campus. Since 2000, he has specialized in the development of molecular and biological assessments of immune response in close collaboration with his wife Olga, an experienced and gifted chemist. Throughout his career, Dr. Kachurin has obtained two Russian patents as well as 18 patents in the United States.
Furthermore, Dr. Kachurin has contributed his wealth of knowledge to a numerous articles and publications. Along with other scholars in the field, he has co-authored “Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies,” “Artificial tissue constructs comprising alveolar cells and methods for using the same” and “Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine.” Prior to entering the field, Dr. Kachurin earned a Doctor of Philosophy in molecular and radiation biophysics at the Leningrad Nuclear Physics Institute in 1985. For his outstanding achievements, Dr. Kachurin was presented with the Best Collaboration Award from the DARPA Chemical and Biological Defense Science and Technology Conference in 2009. In 2015, he accepted the Second Place Science Award from the North American research and development hub of Sanofi. Looking toward the future, Dr. Kachurin intends to experience the continued growth and success of his career while preparing for retirement in the years to come
For more information, please visit:
Contact Dr. Kachurin: